GeneCapture
PrivateLast Round
Seed Round
Feb 26, 2026
Total Funding Raised
$11.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GeneCapture is a biotechnology company developing a portable diagnostic platform designed to rapidly detect and identify pathogens at the point of care.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneCapture Comparables
Compare GeneCapture with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aptitude Medical | 85% | |
| Alveo Technologies | 78% | |
| Anavasi Diagnostics | 77% |
GeneCapture Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Feb 26, 2026 | ||||
| VC Round | Dec 6, 2024 | ||||
| Grant | Mar 15, 2024 | ||||
| Grant | Nov 3, 2023 | ||||
| Grant | May 30, 2023 | ||||
VC Round | Jun 28, 2022 |
Key People
Founding team and executive leadership
GeneCapture Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate Alabama | Grant |
| xTechSearch | Accelerator |
| FedTech | Accelerator |
| Defense Health Agency | Grant |
| Alabama Launchpad | Grant |
| HIS Kingdom Resources Fund | Angel |
| U.S. Department of War | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 26, 2026
Raised $50K in Seed Round funding.
- Dec 6, 2024
$1.5M round raised
GeneCapture Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GeneCapture's valuation, stock price, and market status.
Is GeneCapture a public or private company?
GeneCapture is a private company.
What is the current stock price of GeneCapture?
GeneCapture is a private company with no public stock price. No recent secondary market data is available.
How much is GeneCapture worth (valuation)?
Valuation information for GeneCapture is not publicly available.
Can I buy GeneCapture stock?
GeneCapture shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GeneCapture's last funding round?
GeneCapture's most recent funding round was Seed Round on February 26, 2026.
Who are the main investors in GeneCapture?
Key investors in GeneCapture include Innovate Alabama, Defense Health Agency, Alabama Launchpad, U.S. Department of War, Defense Threat Reduction Agency.
Will GeneCapture IPO soon?
No public IPO plans have been announced for GeneCapture.
How can I track GeneCapture secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GeneCapture's secondary market activity and sign up for updates.